|
KMID : 0383820030550010069
|
|
Tuberculosis and Respiratory Diseases
2003 Volume.55 No. 1 p.69 ~ p.87
|
|
|
A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Oral LB20304 (Gemifloxacin) at Doses of 160mg or 320mg (Equivalent to 200mg or 400mg of the Mesylate Salt) Once Daily for 7 Days for the Treatment of Acute Exacerbati
|
|
김영환/Kim YH
심영수/김원동/심태선/강홍모/최병휘/김재열/권오정/김호중/김주옥/정기석/현인규/모은경/이승준/남귀현/이계영/박재석/Shim YS/Kim WD/Shim TS/Kang HM/Choi BW/Kim JY/Kwon OJ/Kim H/Kim JO/Jung KS/Hyeon IG/Mo EK/Lee SJ/Nam GH/Lee KY/Park JS
|
|
|
Abstract
|
|
|
|
|
|
|
KEYWORD
|
|
|
Gemifloxacin, Fluoroquinolone, Acute exacerbations of chronic bronchitis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|